Structural Differences within Negative and Depressive Syndrome Dimensions in Schizophrenia, Organic Brain Disease, and Major Depression: A Confirmatory Factor Analysis of the Positive and Negative Syndrome Scale

Objective: The emerging dimensional approach to classification and treatment of psychiatric disorders calls for better understanding of diagnosis-related variations in psychiatric syndromes and for proper validation of psychometric scales used for the evaluation of those syndromes. This study tested the hypothesis that negative and depressive syndromes as measured by the Positive and Negative Syndrome Scale (PANSS) are consistent across different diagnoses. Method: We administered the PANSS to subjects with schizophrenia (n = 305), organic brain disease (OBD, n = 66) and major depressive disorder (MDD, n = 75). Confirmatory factor analysis (CFA) was used to establish if the PANSS items for negative symptoms and for depression fit the hypothesized factor structure and if the item factor loadings were similar among the diagnostic groups. Results: The negative and depressive symptom subscales fit well according to a variety of fit indexes for all groups individually after some modest model modification. However, multisample modeling procedures indicated that the pattern of factor loadings was significantly different among the groups in most cases. Conclusion: The results of this study indicate diagnosis-related variations in the negative and depressive syndrome dimensions in schizophrenia, OBD and MDD. These results also validate limited use of the PANSS for evaluation of negative and depressive syndromes in disorders other than schizophrenia. Larger studies are warranted to further evaluate clinical and nosologic significance of diagnostic categories, dimensions and structures of psychiatric syndromes.

[1]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[2]  Julien Bogousslavsky,et al.  Post-stroke depression , 2008, Expert review of neurotherapeutics.

[3]  I. Galynker,et al.  The Negative Syndrome as a Dimension: Factor Analyses of PANSS in Major Depressive Disorder and Organic Brain Disease Compared With Negative Syndrome Structures Found in the Schizophrenia Literature , 2007, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[4]  Patricia S. Jones,et al.  Assessing Cross-Cultural Differences Through Use of Multiple-Group Invariance Analyses , 2006, Journal of personality assessment.

[5]  Sung-Wan Kim,et al.  Diagnostic validity of assessment scales for depression in patients with schizophrenia , 2006, Psychiatry Research.

[6]  É. Fakra,et al.  Intérêt des antidépresseurs chez le patient schizophrène présentant un syndrome dépressif , 2006 .

[7]  D. Rujescu,et al.  Factor structure and external validity of the PANSS revisited , 2006, Schizophrenia Research.

[8]  G. Trendler,et al.  Schizophrenia and depression: Challenging the paradigm of two separate diseases—A controlled study of schizophrenia, depression and healthy controls , 2005, Schizophrenia Research.

[9]  J. Darcourt,et al.  Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease , 2004, International journal of geriatric psychiatry.

[10]  A. Serretti,et al.  Dimensions of major psychoses: a confirmatory factor analysis of six competing models , 2004, Psychiatry Research.

[11]  R. Petersen,et al.  A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. , 2003, The American journal of psychiatry.

[12]  E. Daneluzzo,et al.  PANSS factors and scores in schizophrenic and bipolar disorders during an index acute episode: a further analysis of the cognitive component , 2002, Schizophrenia Research.

[13]  I Litvan,et al.  Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. , 2001, The Journal of neuropsychiatry and clinical neurosciences.

[14]  K. Carey,et al.  Assessing positive and negative symptoms in outpatients with schizophrenia and mood disorders. , 2000, The Journal of nervous and mental disease.

[15]  Richard G. Brown,et al.  Negative symptoms: the ‘pathology’ of motivation and goal-directed behaviour , 2000, Trends in Neurosciences.

[16]  T. Patterson,et al.  Depressive symptoms in schizophrenia. , 1999, The American journal of psychiatry.

[17]  D. Stein,et al.  Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder. , 1999, The Journal of clinical psychiatry.

[18]  J. Jackson,et al.  Evolution and Dissolution of the Nervous System , 1998 .

[19]  K. Davis,et al.  Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. , 1998, Archives of general psychiatry.

[20]  R. Rosenthal,et al.  Negative symptoms in stroke patients and length of hospital stay. , 1997, The Journal of nervous and mental disease.

[21]  R. Murray,et al.  Serotonergic function and negative and depressive symptomatology in schizophrenia and major depression , 1997, Psychoneuroendocrinology.

[22]  Philip D. Harvey,et al.  Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. , 1995, The American journal of psychiatry.

[23]  I. Galynker,et al.  Negative symptoms in patients with basal ganglia strokes , 1994, Biological Psychiatry.

[24]  J. Lieberman,et al.  Depression in first-episode schizophrenia. , 1993, The American journal of psychiatry.

[25]  J. Cummings,et al.  A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. , 1993, The American journal of psychiatry.

[26]  Y Kano,et al.  Can test statistics in covariance structure analysis be trusted? , 1992, Psychological bulletin.

[27]  Jean Addington,et al.  Reliability and validity of a depression rating scale for schizophrenics , 1991, Schizophrenia Research.

[28]  R. Chadda,et al.  A study of negative symptoms in schizophrenia and depression. , 1987, Comprehensive psychiatry.

[29]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[30]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[31]  J. Jackson Remarks on Evolution and Dissolution of the Nervous System , 1887 .

[32]  O. Blin,et al.  [Use of antidepressant drugs in schizophrenic patients with depression]. , 2006, L'Encephale.

[33]  Andrew J Saykin,et al.  Apathy in schizophrenia: reduced frontal lobe volume and neuropsychological deficits. , 2004, The American journal of psychiatry.

[34]  R. Rosenthal,et al.  Hypofrontality and negative symptoms in patients with dementia of Alzheimer type. , 2000, Neuropsychiatry, neuropsychology, and behavioral neurology.

[35]  Philip D. Harvey,et al.  Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. , 1997, Psychopathology.

[36]  R. Doody,et al.  Positive and negative neuropsychiatric features in Alzheimer's disease. , 1995, The Journal of neuropsychiatry and clinical neurosciences.

[37]  Philip D. Harvey,et al.  Empirical assessment of the factorial structure of clinical symptoms in schizophrenic patients: Symptom structure in geriatric and nongeriatric samples , 1994 .

[38]  R. Marin,et al.  Apathy: a neuropsychiatric syndrome. , 1991, The Journal of neuropsychiatry and clinical neurosciences.

[39]  T. Kitamura,et al.  Depressive and negative symptoms in major psychiatric disorders. , 1991, Comprehensive psychiatry.

[40]  S. Sevy,et al.  Pyramidical model of schizophrenia. , 1990, Schizophrenia bulletin.

[41]  Peter M. Bentler,et al.  EQS : structural equations program manual , 1989 .